About Tachi Yamada
Medical professional Dr. Tadataka (Tachi) Yamada currently serves as the executive vice president and chief medical and scientific officer of Takeda Pharmaceuticals. Since joining the company in 2011, he has managed a budget of almost $4 billion, restructured research and development strategies, and increased productivity. Dr. Tachi Yamada also contributes his experience to Takeda's board of directors.
After graduating with distinction from Stanford University with a bachelor of arts in history, Tadataka Yamada earned his doctor of medicine from the New York University School of Medicine. He received further training in internal medicine at the Medical College of Virginia and then accepted a position as an investigator at the United States Army Medical Research Institute of Infectious Diseases. Subsequently, he completed additional training in gastroenterology at the David Geffen School of Medicine at UCLA, where he also received appointment to a faculty position.
Throughout the following years, Dr. Tachi Yamada worked with various educational institutions, pharmaceutical companies, and foundations, including the University of Michigan, where he served as chairman of the Department of Internal Medicine, and GlaxoSmithKline, where he became the physician-in-chief. In 2006, he accepted a position as president of the Global Health Program for the Bill & Melinda Gates Foundation.
After graduating with distinction from Stanford University with a bachelor of arts in history, Tadataka Yamada earned his doctor of medicine from the New York University School of Medicine. He received further training in internal medicine at the Medical College of Virginia and then accepted a position as an investigator at the United States Army Medical Research Institute of Infectious Diseases. Subsequently, he completed additional training in gastroenterology at the David Geffen School of Medicine at UCLA, where he also received appointment to a faculty position.
Throughout the following years, Dr. Tachi Yamada worked with various educational institutions, pharmaceutical companies, and foundations, including the University of Michigan, where he served as chairman of the Department of Internal Medicine, and GlaxoSmithKline, where he became the physician-in-chief. In 2006, he accepted a position as president of the Global Health Program for the Bill & Melinda Gates Foundation.